Showing 1331-1340 of 1554 results for "".
- Neuro-Optometric Rehabilitation Association Announces Appointments of New Executive and Advisory Board Officershttps://modernod.com/news/neuro-optometric-rehabilitation-association-announces-appointments-of-new-executive-and-advisory-board-officers/2478297/The Neuro-Optometric Rehabilitation Association (NORA) announced the appointments of its new executive and advisory board members. DeAnn Fitzgerald, OD, assumes the position of President, succeeding Susan Daniel, OD, who now joins the NORA Advisory Board. Dr. Fitzgerald has been providing
- Stephen D. McLeod, MD, Selected as Next CEO of American Academy of Ophthalmologyhttps://modernod.com/news/stephen-d-mcleod-md-selected-as-next-ceo-of-american-academy-of-ophthalmology/2480346/The American Academy of Ophthalmology board of trustees announced the unanimous selection of Stephen D. McLeod, MD, 57, as the Academy’s next chief executive officer (CEO). Dr. McLeod currently is the Theresa M. and Wayne M. Caygill, M.D. Distinguished Professor and Chair, Department of Oph
- NASA Astronauts to Headline Heidelberg Engineering’s 2025 International Spectralis Symposiumhttps://modernod.com/news/nasa-astronauts-to-headline-heidelberg-engineerings-2025-international-spectralis-symposium/2482818/Heidelberg Engineering announced that NASA astronauts Warren Hoburg and Tyson Brunstetter, OD, PhD, will lead the keynote presentation at the company’s
- EyeCheq adds Jai G. Parekh, MD, to its Executive Teamhttps://modernod.com/news/eyecheq-adds-jai-g-parekh-md-mba-to-its-executive-team/2481428/EyeCheq, the developer of a fully autonomous eye screening platform using artificial intelligence (AI), announced that Jai G. Parekh, MD, FAAO, has been named Executive Vice-President and Chief Innovation Officer. Dr. Parekh, a dual-train
- American Academy of Optometry Announces Peter Scott as New Executive Directorhttps://modernod.com/news/american-academy-of-optometry-announces-peter-scott-as-new-executive-director/2476390/The American Academy of Optometry has announced that Peter Scott, CAE, APR, MBA will assume the position of executive director in mid-April 2019. The Academy’s outgoing Executive Director, Lois Schoenbrun, CAE, FAAO, will retire from her position at the end of April. Ms. Schoenbrun has been execu
- Three Optometric Practices in Florida Partner With US Eyehttps://modernod.com/news/us-eye-expands-into-now-5-states-50-clinics-and-5-ascs-100-providers-and-1000-team-members/2480526/Three optometric practices in Florida have partnered with US Eye. The new partnerships include Rick Billings, OD; Hart Eye Care; and Precision Eye Care of Central Florida.
- Trump to Nominate Stephen Hahn, Cancer Researcher, to Head FDAhttps://modernod.com/news/trump-to-nominate-stephen-hahn-cancer-researcher-to-head-fda/2477068/President Trump said Friday that he intended to nominate Stephen M. Hahn, MD, a top executive at The University of Texas M.D. Anderson Cancer Center, to be the next commissioner of the Food and Drug Administration, according to a
- AOA: Changes on the Horizon for Evaluation and Management Serviceshttps://modernod.com/news/aoa-changes-on-the-horizon-for-evaluation-and-management-services/2477202/There has been a lot of information disseminated by various individuals and organizations regarding upcoming changes to coding and reimbursement for evaluation and management services (E/M services). Given the importance of E/M services in patient care, it’s critical that all doctors of opt
- Oculis Appoints New Members of Senior Management Teamhttps://modernod.com/news/oculis-appoints-new-members-of-senior-management-team/2479655/Oculis announced the appointments of Fabio Baschiera, PharmD, MPh, PhD, as Vice President of Clinical Development, and Louie-Anne Gauthier, M.Sc., as Vice President of Strategic Marketing, Business Development and Licensing. “We are delighted to welcome Fabio and Louie-Anne to the Oculis m
- Aurion Makes Leadership Announcementshttps://modernod.com/news/aurion-makes-leadership-announcements/2482757/Aurion Biotech announced the appointments of Edward J. Holland, MD, as Chief Medical Officer, and Eris P. Jordan, OD, as Chief Development Officer. Aurion is developing AURN001, an investigational, single-administration, allogeneic cell therapy for the treatment of corneal edema seconda